0001666071-21-000085.txt : 20210511 0001666071-21-000085.hdr.sgml : 20210511 20210511161431 ACCESSION NUMBER: 0001666071-21-000085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210507 FILED AS OF DATE: 20210511 DATE AS OF CHANGE: 20210511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laube Lynne Marie CENTRAL INDEX KEY: 0001730687 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 21911468 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_162076404922676.xml FORM 4 X0306 4 2021-05-07 0 0001666071 Cardlytics, Inc. CDLX 0001730687 Laube Lynne Marie C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 1 1 0 0 Chief Executive Officer Common Stock 2021-05-07 4 S 0 1453 100.24 D 315714 D Common Stock 2021-05-07 4 S 0 2300 101.08 D 313414 D Common Stock 2021-05-07 4 S 0 2900 102.33 D 310514 D Common Stock 2021-05-07 4 S 0 1900 103.48 D 308614 D Common Stock 2021-05-07 4 S 0 500 104.36 D 308114 D Common Stock 14565 I See Footnote Common Stock 14565 I See Footnote Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $99.81 to $100.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5) and (6) to this Form 4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.82 to $101.50, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $101.88 to $102.83, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $102.925 to $103.915, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $104.06 to $104.97, inclusive. The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright (the "KGA GRAT"). The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright (the "HMA GRAT"). /s/ Kirk Somers, Attorney-in-Fact 2021-05-11